The Efficacy and Safety of Modified Docetaxel, Cisplatin, and 5-Fluorouracil Vs. Epirubicin, Oxaliplatin, and Capecitabine Regimen in the Advanced Gastric Cancer: A Randomized Controlled Clinical Trial

INTRODUCTION: One of the major challenges of advanced gastric cancer treatment is the lack of a standard regimen for patients. However, several clinical trials have shown that modified docetaxel, cisplatin, and 5-fluorouracil (m-DCF) and epirubicin, oxaliplatin, and capecitabine (EOX) regimens are s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadzadeh, Ahmad, Seyedian, Seyed Saeid, Valizadeh, Armita, Soleimani, Mahin, Nazari, Pedram, Hamidi, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437336/
https://www.ncbi.nlm.nih.gov/pubmed/32212800
http://dx.doi.org/10.31557/APJCP.2020.21.3.727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437336/
https://www.ncbi.nlm.nih.gov/pubmed/32212800
http://dx.doi.org/10.31557/APJCP.2020.21.3.727

Ejemplares similares